Human papillomavirus and human immunodeficiency virus as risk factors for cervical cancer among imprisoned women;Infecciön por los virus del papiloma humano y de la inmunodeficiencia humana como factores de riesgo para el cáncer de cuello uterino en mujeres reclusas human papillomavirus and human immunodeficiency virus as risk factors for cervical cancer among imprisoned women

Medicina Clinica

Volumn 115, Issue 3, 2000, Pages 81-84

  De Sanjosé, Silvia ^a,d   Valls, Imma ^b   Cañadas, M Paz ^c   Lloveras, Belén ^c   Quintana, M Jesús ^a   Shah, Keerti V ^e   Bosch, Francesc Xavier ^a  

^a CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^b Centro Penitenciario de Mujeres   (Spain)

^c General Lab   (Spain)

^d HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^e NONE

Author keywords

Cervical cancer screening; Human immunodeficiency virus; Human papillomavirus; Prison

Indexed keywords

VIRUS ANTIBODY; VIRUS DNA;

ADOLESCENT; ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; COMPARATIVE STUDY; DRINKING BEHAVIOR; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETICS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; PAPILLOMA VIRUS; POLYMERASE CHAIN REACTION; PRISONER; PROSTITUTION; RISK; RISK FACTOR; SMOKING; SUBSTANCE ABUSE; UTERINE CERVIX TUMOR; VIROLOGY; VIRUS INFECTION;

ADOLESCENT; ADULT; ALCOHOL DRINKING; ANTIBODIES, VIRAL; CD4 LYMPHOCYTE COUNT; DNA, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HIV; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMANS; ODDS RATIO; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; PRISONERS; PROSTITUTION; RISK FACTORS; SMOKING; SUBSTANCE ABUSE, INTRAVENOUS; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS;

EID: 0034679141     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0025-7753(00)71472-2     Document Type: Article

References (20)

1. IARC monographs on the evaluation of carcinogenic risks to humans: human papillomaviruses. Lyon, Francia: International Agency for Research on Cancer, 1995; vol. 64.
2. Bosch FX, Castellsagué X, Mun̄oz N, De Sanjosé S, Ghaffari AM, Gonzalez LC et al. Male sexual behavior and human papillomavirus DNA: key risk factors for cervical cancer in Spain. J Natl Cancer Inst 1996; 88: 1060-1067.
3. De Sanjosé S, Mun̄oz N, Bosch FX, Reimann K, Pedersen NS, Orfilia J et al. Sexually transmitted agents and cervical neoplasia in Colombia and Spain. Int J Cancer 1994; 56: 358-363.
4. Palacio V, De Sanjosé S, Vázquez S, Puente M, Vazquez F, Bosch FX. Cervical neoplasia and sexually transmitted diseases among prostitutes in Oviedo, Spain Int J STD AIDS 1993; 4: 121-123.
5. Laga M, Icenogle JP, Marsella R, Manoka AR, Nzila N, Ryder RW et al. Genital papillomavirus infection and cervical dysplasia -opportunistic complications of HIV infection. Int J Cancer 1992; 50: 45-48.
6. Icenogle JP, Laga M, Miller D, Tucker MA, Reeves WC. Genotypes and sequence variants of human papillomavirus DNAs from human immunodeficiency virus type 1-infected women with cervical intraepithelial neoplasia. J Infect Dis 1992; 166: 1210-1216.
7. Martin V, Caylá JA, Moris ML, Alonso LE, Pérez R. Evolución de la prevalencia de infección por virus de la inmunodeficiencia humana en población reclusa al ingreso en prisión durante el periodo 1991-95. Rev Esp Salud Pública 1997; 71: 269-280.
8. Palefsky JM, Minkoff H, Kalish LA, Levine A, Sacks HS, Garcia P et al. Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)-positive and high-risk HIV-negative women. J Natl Cancer Inst 1999; 91: 226-236.
9. Hildesheim A, Gravitt P, Schiffman MH, Kurman RJ, Barnes W, Jones S et al. Determinants of genital human papillomavirus infection in low-income women in Washington, D.C. Sex Transm Dis 1993; 20: 279-284.
10. Cañadas MP, Martínez F, De Sanjosé S, Valls I, Llcveras B, Bosch FX et al. Detección del ADN del virus del papiloma numano por PCR en mujeres de alto riesgo. Validación de un protocole. Enferm Infecc Microbio Clin 1998; 16: 400-403.
11. De Sanjosé S, Bosch FX, Valls I, Can̄adas MP, Lloveras B, Castellsagué X, and Shah KV. Prevalence of HPV cervical infections among imprisoned women in Barcelona, Spain. Sex Transm Infect 2000; 76: 58-66.
12. Cappiello G, Garbuglia AR, Salvi R, Rezza G, Giuliani M, Pezzotti P et al. HIV infection increases the risk of squamous intra-epithelial lesions in women with HPV infection: an analysis of HPV genotypes. DIANAIDS Collaborative Study Group. Int J Cancer 1997; 72: 982-986.
13. Vall M, Maguire A, Mirel M, Casabona J. Dispoportionate high incidence of invasive cervical cancer as an AIDS-indicative disease among young women in Catalonia, Spain. Sex Transm Dis 1999; 26: 500-503.
14. Ho GYF, Bierman R, Beardsley L, Chang CJ, BurK RD. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 1998; 338: 423-428.
15. Van Doornum GJJ, Van den Hoeck JAR, Van Ameijden EJC, Van Haastrecht, Roos MThL, Henquet CJM et al. Cervical HPV infection among HIV-infected prostitutes addicted to hard drugs. J Med Virol 1993; 41: 185-190.
16. Vernon SD, Reeves WC, Clancy KA, Lega M, St Loius M, Gary HE et al. A longitudinal study of human papillomavirus DNA detection in human immunodeficiency virus typel-seropositive and seronegative women. J Infect Dis 1994; 169: 1108-1112.
17. Melbye M, Smith E, Wohlfarhrt J, Osterlind A, Orholm M, Bergmann OJ et al. Anal and cervical abnormality in women-prediction by human papillomavirus tests. Int J Cancer 1996; 68: 559-564
18. Langley CL, Benga-De E, Ndoye I, Mbengue-Ly MD, Kuypers J, Woto-Gaye G et al. HIV-1, HIV-2 human papillomavirus infection and cervical neoplasia in high-risk African women. AIDS 1996; 10:413-417.
19. Muñoz N, Kato I, Bosch FX, Eluf-Neto J, De Sanjosé S, Ascunce N et al. Risk factors for DNA detection in midle-aged women. Sex Transm Dis 1996; 23: 504-510.
20. Schneider A, Koutsky LA. Natural history and epidemiological features of genital HPV infection. En: Muñoz N, Bosch FX, Shah KV, Meheus A. editores. The epidemiology of human papillomavirus and cervical cancer. Lyon, Francia: IARC Scientific Publications, n.o 119, International Agency for Research on Cancer, 1992; 25-52.